期刊文献+

短C肽门冬胰岛素制备工艺的研究

Research on Preparation of Insulin Aspart with Short C-Peptide
下载PDF
导出
摘要 为研究门冬胰岛素制备工艺,参照毕赤酵母偏好密码子,设计合成N-端连接引导肽EEAEAEAEPK,以KEWK作为短C肽,A、B链结构完整的门冬胰岛素c DNA序列。利用Xho I-Not I酶切位点将其插入表达质粒p PICZαA,采用电转移方法将重组质粒转入毕赤酵母x-33,筛选高拷贝重组子作为工程菌株进行高密度发酵,表达量可达到0.57 g/L。发酵液经金属螯合层析和SP阳离子层析纯化后鉴定正确。建立CPB/Trypsin双酶切工艺,对不同温度及p H条件下产生的酶切产物进行分析,初步建立了酶切最佳p H值和温度条件。酶切产物经纯化后制得纯度为91.7%的门冬胰岛素,副产物为B链30位缺失的门冬胰岛素。该设计方法为含短C肽EWK门冬胰岛素制备中选用Lys-c酶切成本过高的问题提供了备选解决方案。 In order to study the preparation techniques of insulin aspart,we designed and linked EEAEAEPK to its N-terminal,referring to the preference codons of pichia pastoris,and took KEWK as C-peptide,which was a synthetise insulin aspart c DNA sequence with integrated A,B chain structure. We inserted the target sequence into expression plasmid p PICZαA by the restriction enzyme sites Xho I and Not I. The combination of P. Pastoris / x-33 was constructed by electrotransformation and the high-yield strain was selected. The combinant strain expressed 0. 57 g / L at the 64 th hours of fermentation. We obtained the purer insulin aspart precursor from broth through metal ion-affinity chromatography,SP ion-exchange chromatography and the result of authentication was correct. The system of enzyme digestion by CPB / Trypsin was established and probed the effect in different p H and temper-ature. The product after enzyme digestion was made into insulin aspart and the by-product was insulin aspart Des B30. The purity of insulin aspart reached 91. 7%. This design would be another choice to the preparation of insulin aspart,compared with which with short C-peptide EWK,as its high cost in use of Lys-c.
出处 《重庆理工大学学报(自然科学)》 CAS 2015年第4期60-66,共7页 Journal of Chongqing University of Technology:Natural Science
关键词 门冬胰岛素 毕赤酵母 短C肽 纯化 insulin aspart pichia pastoris short C-peptide purification
  • 相关文献

参考文献12

二级参考文献41

  • 1Raskin PR,Allen E, Hollander P,et al. Initiating insulin therapy in type 2 diabetes. Diabetes Care, 2005,28:260-265.
  • 2Holman RR, Thorne KI, Farmer AJ, et al. Addition of biphasic, prandial or basal insulin to oral therapy in type 2 diabetes. N Engl J Med ,2007, 357(17):1716-1730.
  • 3Jang HC, Guler S, Shestakova M, et al. When glycaemic targets can no longer be achieved with basal insulin in type 2 diabetes, can simple intensification with a modern premixed insulin help results from a subanalysis of the Present Study. Int J Clin Pract,2008,62(7) :1013-1018.
  • 4Garber AJ, Wahlen J, Wahl T, et al. Attainment of glycaemic goals in type 2 diabetes with once, twice or thrice-daily dosing with biphasic insulin aspart 70/30 (the 1-2-3 study). Diabetes Obes Metab, 2006,8:58-66.
  • 5Yang WJ,Ji QH, Zhu DL, et al. Biphasie insulin aspart 30 three times daily is more effective than a twice-daily regimen, without increasing hypoglycemia, in Chinese subjects with type 2 diabetes inadequately controlled on OADs. Diabetes Care, 2008 ,31:852-856.
  • 6Liebl A, Prager R, Binz K,et al. Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the Prefer Study: a randomized controlled trial. Diabetes, Obesity and Metabolism,2009,11(1) :45-52.
  • 7Miyashita Y, Nishimura R, Nemoto M, et al. Prospective randomized study for optimal insulin therapy in type 2 diabetic patients with secondary failure. Cardiovasc Diabetol,2008 ,29(7):16.
  • 8Ligthelm RJ, Mouritzen U, Lynggaard H, et al. Biphasic insulin aspart given thrice daily is as efficacious as a basal-bolus insulin regimen with four daily injections: a randomised openlabel parallel group four months comparison in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes, 2006,114(9) : 511-519.
  • 9Mortensen H, Kocova M, Teng LY, et al. Biphasic insulin aspart vs human insulin in adolescents with type 1 diabetes on multiple daily insulin injections. Pediatr Diabetes, 2006,7:1-3.
  • 10Chen JW, Lauritzen T, Bojesen A, et al. Multiple mealtime administration of biphasie insulin aspart 30 versus traditional basal--bolus human insulin treatment in patients with type 1 diabetes. Diabetes Obes Metab, 2006,8 : 682-689.

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部